ASUKA KODA & EDIS MESIC
Yale spin-off company Modifi Bio acquired by Merck in multimillion dollar deal
Modifi Bio’s founders discuss the journey from developing a cancer treatment drug to being acquired by Big Pharma.
November 14, 2024